Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

janssen_latest_logo_on_sign_closer

Janssen’s Zytiga boosts survival in early-stage prostate cancer

March 14, 2016 Research and Development, Sales and Marketing Janssen, Zytiga, abiraterone, prednisone, prostate cancer

Janssen has announced data from a post-hoc analysis of a Phase III trial showing that Zytiga plus prednisone boosted overall …
News
xalkori

FDA approves Pfizer sNDA for Xalkori

March 14, 2016 Research and Development, Sales and Marketing Cancer, EMA, NSCLC, Pfizer, Xalkori (crizotinib)

The US FDA has approved Pfizer’s supplemental new drug application (sNDA) for its kinase inhibitor Xalkori in treating patients with …
News
gilead-sciences

EMA starts review of Gilead Sciences’ Zydelig following safety concerns

March 14, 2016 Research and Development, Sales and Marketing EMA, Gilead Sciences, blood cancer, clinical trials, zydelig

Regulators in Europe have initiated a safety review of Gilead Sciences’ (Nasdaq: GILD) blood cancer drug Zydelig (idelalisib) following reports …
News
five_prime_therapeutics_scientist

GSK terminates Five Prime Therapeutics mesothelioma collaboration

March 14, 2016 Research and Development, Sales and Marketing Five Prime Therapeutics, GSK, mesothelioma

GSK is to back out of a licensing deal with California-based Five Prime Therapeutics to develop a mesothelioma drug. Announcing …
News

MSF challenges Pfizer’s pneumonia vaccine patent in India

March 11, 2016 Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine

The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …
News
arzerra_novartis

Novartis seeks expanded Arzerra use in US

March 11, 2016 Research and Development Arzerra, CLL, FDA, Genmab, Novartis

Novartis has submitted a supplemental Biologics License Application (sBLA) to the US FDA for the use of Arzerra (ofatumumab) in …
News
shutterstock_38078521

US FDA sets April 25 date to review Sarepta’s DMD drug, shares jump

March 11, 2016 Medical Communications, Research and Development Duchenne Muscular Dystrophy, Eteplirsen, Sarepta Therapeutics, US FDA

Shares in US-based Sarepta Therapeutics (Nasdaq: SRPT) jumped nearly 15% Thursday after the US Food and Drug Administration (FDA) said it …
News
ivf_worldwide_teva_logos

Teva funds research to protect fertility in women diagnosed with cancer

March 11, 2016 Business Services, Research and Development Cancer, IVF Worldwide, Teva, fertility, radiotherapy

Israeli generics giant Teva has announced it will support IVF-Worldwide with a research grant to improve knowledge of fertility preservation …
News
vials_purple_liquid

Alphabet’s life science unit makes device to aid gathering of health data for research

March 11, 2016 Medical Communications, Research and Development Alphabet, Connectivity Bridge, Verily, google, life sciences

Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for …
News
sanofi_logo_on_building

Sanofi says its RA drug bested Humira in Phase III study

March 11, 2016 Medical Communications, Research and Development Humira, Regeneron, Sanofi

Sanofi and its R&D arm Regeneron Pharmaceuticals say their monoclonal antibody sarilumab outperformed AbbVie’s Humira in treating the symptoms of …
News
shutterstock_212432119

Vericel stock nearly doubles as heart failure drug meets primary endpoint in mid-stage trial

March 11, 2016 Medical Communications, Research and Development

Shares in US-based biotech firm Vericel nearly doubled on the Nasdaq on Thursday as the company reported its heart failure …
News

FDA grants approval for first generic version of Viagra

March 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Pfizer, Teva, erectile dysfunction, generic, viagra

The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

Two-drug combo shown to significantly shrink breast cancer in days

March 10, 2016 Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb

Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …
News
research_11

Researcher develops strategy to identify antimicrobial drugs that tackle drug-resistant pathogens

March 10, 2016 Manufacturing and Production, Research and Development anitmicrobial, drug discovery, drug repurposing, mohamed seleem, purdue university

A researcher from Purdue University’s College of Veterinary Medicine has developed a novel method of repurposing drugs to act as …
News
amarin_logo

Amarin wins case against FDA to promote Vascepa for off-label uses

March 10, 2016 Medical Communications, Research and Development, Sales and Marketing Amarin, FDA, first amendment, off label, vascepa

Amarin has announced a settlement with the US Food and Drug Administration (FDA) that resolves the dispute over the Irish-based …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025